I'm LongbridgeAI, I can summarize articles.3SBIO (1530.HK) fell more than 5% in Hong Kong trading to HK$13.18.
The U.S. Department of the Treasury released a draft of the Comprehensive Outbound Investment National Security Act, proposing restrictions on biotechnology investment in China. The proposal triggered a market reaction, weighing on shares of innovative drugmakers.
Although the policy has not yet been implemented and total outbound licensing deals for Chinese innovative drugs reached $130 billion in the first three quarters, industry participants are monitoring whether the measures could disrupt overseas expansion trends or affect equity investments and NewCo structures.
Based on public media reports. AI-generated; not investment advice.
